Fenbufen
| |
| |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
ECHA InfoCard |
100.048.148 |
Chemical and physical data | |
Formula | C16H14O3 |
Molar mass | 254.2854 |
3D model (JSmol) | |
| |
| |
|
Fenbufen is a nonsteroidal anti-inflammatory drug in the propionic acid derivatives class.[1]
It was introduced by American Cyanamid under the trade name Lederfen in the 1980s and was withdrawn from markets in the developed world due to liver toxicity in 2010.[2][3]:370, 383-384
As of 2015 it was available in Taiwan and Thailand under several brand names.[4]
References
- ↑ Brogden RN. Non-steroidal anti-inflammatory analgesics other than salicylates. Drugs. 1986;32 Suppl 4:27-45. Review. PMID 3552584
- ↑ Monthly Index of Medical Specialities Deleted products 2010
- ↑ Lewis JH and Stine JG. Nonsteroidal Antiinflammatory Drugs and Leukotriene Receptor Antagonists. Chapter 22 in Drug-Induced Liver Disease, 3rd Edition. Eds Neil Kaplowitz N and DeLeve LD. Academic Press, 2013 ISBN 9780123878182
- ↑ Drugs.com Drugs.com international listings for fenbufen Page accessed June 25, 2015
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.